A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

Condition:   X-Linked Retinitis Pigmentosa Intervention:   Biological: rAAV2tYF-GRK1-hRPGRco Sponsor:   Applied Genetic Technologies Corp Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials